Caspofungin Acetate Isomer Impurity |
|
|---|---|
| CAT. No : | C1240037 |
| CAS. No : | NA |
| Mol. F : | C52H88N10O15 |
| Mol. Wt : | 1093.31 g/mol |
| Synonyms : | NA |
| Chemical Name : | N-((2R,6S,9S,11R,12S,14aS,15S,20S,23S,25aS)-20-((R)-3-amino-1-hydroxypropyl)-12-((2-aminoethyl)amino)-23-((1S,2R)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl)-2,11,15-trihydroxy-6-((R)-1-hydroxyethyl)-5,8,14,19,22,25-hexaoxotetracosahydro-1H-dipyrrolo[2,1-c:2`,1`-l][1,4,7,10,13,16]hexaazacyclohenicosin-9-yl)-10,12-dimethyltetradecanamide |
| Stock Status : | Custom Synthesis |
- Smiles:O=C(N([C@@]1(C(N[C@H](NCCN)[C@H](O)C[C@H](NC(CCCCCCCCC(CC(CC)C)C)=O)C(N[C@]2([C@@H](C)O)[H])=O)=O)[H])CC[C@@H]1O)[C@]([H])([C@@H](CCN)O)NC([C@H]([C@@H]([C@H](O)C3=CC=C(C=C3)O)O)NC([C@]4([H])C[C@H](CN4C2=O)O)=O)=O
- Buy Caspofungin Acetate Isomer Impurity from Simson Pharma Limited at best competitive price.
- Simson Pharma provides best quality Caspofungin Acetate Isomer Impurity.
- Every compound produced by Simson Pharma is accompanied by Certificate of Analysis.
Page Keywords:
Buy high quality Caspofungin Acetate Isomer Impurity | Purchase Caspofungin Acetate Isomer Impurity | Caspofungin Acetate Isomer Impurity suppliers | Caspofungin Acetate Isomer Impurity manufacturers | Caspofungin Acetate Isomer Impurity price | Caspofungin Acetate Isomer Impurity exporter | Order Caspofungin Acetate Isomer Impurity | Enquire Caspofungin Acetate Isomer Impurity | Caspofungin Acetate Isomer Impurity cost | Caspofungin Acetate Isomer Impurity Supplier | Caspofungin Acetate Isomer Impurity Distributor
Disclaimer:
The information provided on this webpage is based on the best available knowledge at the time of creation. However, accuracy and completeness are not guaranteed. Product specifications may change without notice, and it is the responsibility of the purchaser, user, or importer of record to verify the accuracy and suitability of the product at the time of ordering.
This product is intended for research use only and is not approved for human consumption.
